Data for Naito, 2021, Combined Use of a Polycarboxybetaine Coating and a Selective Factor XII Inhibitor Markedly Reduces Artificial Surface Clot Formation While Preserving Normal Tissue Coagulation During Extracorporeal Life Support

Name: Data for Naito, 2021, Combined Use of a Polycarboxybetaine Coating and a Selective Factor XII Inhibitor Markedly Reduces Artificial Surface Clot Formation While Preserving Normal Tissue Coagulation During Extracorporeal Life Support
Creator: Keith Cook
Published: 2021-01-20T19:06:21.855Z
Keywords: Biomedical Engineering, Critical Care, Extracorporeal Membrane Oxygenation, Extracorporeal Life Support

Cook, Keith

doi:10.17632/tg8dntkgsc.1

Data for Naito, 2021, Combined Use of a Polycarboxybetaine Coating and a Selective Factor XII Inhibitor Markedly Reduces Artificial Surface Clot Formation While Preserving Normal Tissue Coagulation During Extracorporeal Life Support

Published: 20-01-2021| Version 1 | DOI: 10.17632/tg8dntkgsc.1

Contributor:

Keith Cook

Description

This data is in support of our study examining the combined use of polycarboxybetaine coatings and FXII inhibition during extracorporeal life support in rabbits.

Files

Steps to reproduce

Please see paper by Naito N., Ukita R., et al.